Neonatal Encephalopathy & Pseudo-TORCH Syndromes: Case Report
- A recently documented case highlights the challenges in diagnosing rare genetic disorders that present with symptoms similar to more common neonatal conditions.Specifically, a deficiency in the USP18 gene...
- USP18 is crucial for regulating the body's interferon response, a key component of the immune system.
- The infant presented with symptoms consistent with severe neonatal encephalopathy, including seizures and altered mental status.Standard TORCH infection screening tests were initially inconclusive, but the clinical picture remained...
Rare Genetic Deficiency Mimics Common Neonatal Infection
Table of Contents
Published September 10, 2024, at 08:12 AM
Understanding USP18 Deficiency
A recently documented case highlights the challenges in diagnosing rare genetic disorders that present with symptoms similar to more common neonatal conditions.Specifically, a deficiency in the USP18 gene can manifest as severe neonatal encephalopathy, initially resembling a TORCH infection (Toxoplasmosis, Other agents, Rubella, Cytomegalovirus, Herpes simplex virus). This overlap, termed a “pseudo-TORCH syndrome,” can lead to delayed or incorrect diagnoses.
USP18 is crucial for regulating the body’s interferon response, a key component of the immune system. A lack of functional USP18 disrupts this response, leaving newborns vulnerable to severe illness. The case report details a newborn exhibiting significant neurological impairment shortly after birth, prompting initial investigation for infectious causes.
Clinical Presentation and Diagnostic Challenges
The infant presented with symptoms consistent with severe neonatal encephalopathy, including seizures and altered mental status.Standard TORCH infection screening tests were initially inconclusive, but the clinical picture remained concerning. Further genetic testing ultimately revealed a homozygous pathogenic variant in the USP18 gene, confirming the diagnosis.
the diagnostic delay underscores the importance of considering rare genetic etiologies,even when initial presentation suggests a more common infectious cause. Misdiagnosis can lead to inappropriate treatment and possibly worsen outcomes. A high index of suspicion for genetic disorders is especially crucial in cases where typical TORCH infection markers are absent or atypical.
Implications for Newborn Care
This case emphasizes the need for expanded newborn screening panels to include rare genetic conditions that can mimic infectious diseases. Early and accurate diagnosis is critical for appropriate management, which may include supportive care and, potentially, future gene therapy interventions.
the recognition of USP18 deficiency as a cause of pseudo-TORCH syndrome expands the differential diagnosis for neonatal encephalopathy. Clinicians should be aware of this possibility and consider genetic testing when initial investigations are unrevealing. Further research is needed to understand the full spectrum of clinical manifestations and optimal treatment strategies for USP18 deficiency.